Carregant...
Tipus de document
ArticleVersió
Versió acceptadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/149097
Securing sustainable funding for viral hepatitis elimination plans
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
The majority of people infected with chronic hepatitis C
virus (HCV) in the European Union (EU) remain undiagnosed and
untreated. During recent years, immigration to EU has further
increased HCV prevalence. It has been estimated that, out of the
4.2 million adults affected by HCV infection in the 31 EU/
European Economic Area (EEA) countries, as many as
580\xC2\xA0000 are migrants. Additionally, HCV is highly
prevalent and under addressed in Eastern Europe. In 2013, the
introduction of highly effective treatments for HCV with
direct-acting antivirals created an unprecedented opportunity to
cure almost all patients, reduce HCV transmission and eliminate
the disease. However, in many settings, HCV elimination poses a
serious challenge for countries' health spending. On 6 June
2018, the Hepatitis B and C Public Policy Association held the
2nd EU HCV Policy summit. It was emphasized that key
stakeholders should work collaboratively since only a few
countries in the EU are on track to achieve HCV elimination by
2030. In particular, more effort is needed for universal
screening. The micro-elimination approach in specific
populations is less complex and less costly than country-wide
elimination programmes and is an important first step in many
settings. Preliminary data suggest that implementation of the
World Health Organization (WHO) Global Health Sector Strategy on
Viral Hepatitis can be cost saving. However, innovative
financing mechanisms are needed to raise funds upfront for
scaling up screening, treatment and harm reduction interventions
that can lead to HCV elimination by 2030, the stated goal of the
WHO.
Matèries
Matèries (anglès)
Citació
Col·leccions
Citació
HATZAKIS, Angelos, LAZARUS, Jeffrey v., CHOLONGITAS, Evangelos, BAPTISTA LEITE, Ricardo, BOUCHER, Charles a. b., BUSOI, Cristian-silviu, DEUFFIC BURBAN, Sylvie, CHHATWAL, Jagpreet, ESMAT, Gamal, HUTCHINSON, Sharon, MALLIORI, Minerva-melpomeni, MATICIC, Mojca, MOZALEVSKIS, Antons, NEGRO, Francesco, PAPANDREOU, George a., PAPATHEODORIDIS, George v., PECK-RADOSAVLJEVIC, Markus, RAZAVI, Homie, REIC, Tatjana, SCHATZ, Eberhard, TOZUN, Nurdan, YOUNOSSI, V, MANNS, Michael p.. Securing sustainable funding for viral hepatitis elimination plans. _Liver International_. 2020. Vol. 40, núm. 2, pàgs. 260-270. [consulta: 22 de gener de 2026]. ISSN: 1478-3223. [Disponible a: https://hdl.handle.net/2445/149097]